Kayne Anderson Rudnick Investment Management
BIO icon

Kayne Anderson Rudnick Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.6K Hold
135
– – ﹤0.01% 605
2025
Q4 		$40.9K Hold
135
– – ﹤0.01% 607
2025
Q3 		$37.9K Hold
135
– – ﹤0.01% 622
2025
Q2 		$32.6K Hold
135
– – ﹤0.01% 641
2025
Q1 		$32.9K Hold
135
– – ﹤0.01% 611
2024
Q4 		$44.3K Hold
135
– – ﹤0.01% 563
2024
Q3 		$45.2K Hold
135
– – ﹤0.01% 560
2024
Q2 		$36.9K Hold
135
– – ﹤0.01% 553
2024
Q1 		$46.7K Hold
135
– – ﹤0.01% 547
2023
Q4 		$43.6K Hold
135
– – ﹤0.01% 533
2023
Q3 		$48.4K Hold
135
– – ﹤0.01% 515
2023
Q2 		$51.2K Hold
135
– – ﹤0.01% 498
2023
Q1 		$64.7K Hold
135
– – ﹤0.01% 477
2022
Q4 		$56.8K Hold
135
– – ﹤0.01% 502
2022
Q3 		$56K Hold
135
– – ﹤0.01% 472
2022
Q2 		$67K Hold
135
– – ﹤0.01% 461
2022
Q1 		$76K Hold
135
– – ﹤0.01% 444
2021
Q4 		$102K Hold
135
– – ﹤0.01% 448
2021
Q3 		$101K Hold
135
– – ﹤0.01% 433
2021
Q2 		$87K Hold
135
– – ﹤0.01% 445
2021
Q1 		$77K Hold
135
– – ﹤0.01% 437
2020
Q4 		$79K Hold
135
– – ﹤0.01% 420
2020
Q3 		$70K Hold
135
– – ﹤0.01% 404
2020
Q2 		$61K Hold
135
– – ﹤0.01% 393
2020
Q1 		$47K Buy
+135
New +$49.6K ﹤0.01% 394

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's BIO Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q1 2026 at 135 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #605.

Kayne Anderson Rudnick Investment Management first reported a position in BIO in Q1 2020 and has held it in 25 quarters since. The position peaked at $102K in Q4 2021. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 135 shares of Bio-Rad Laboratories Class A worth $37.6K as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management left its Bio-Rad Laboratories Class A share count unchanged in Q1 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #605 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and has held it in 25 quarters since.
  • Kayne Anderson Rudnick Investment Management's Bio-Rad Laboratories Class A position peaked at $102K in Q4 2021.
  • 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.